🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨The FDA granted accelerated approval to avutometinib & defactinib for adults with KRAS-mutated recurrent low-grade serous #ovariancancer. Congrats to MSK's Rachel Grisham, Global Lead Principal Investigator of GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301! bit.ly/3ETZS2F

New paper finding #ovarian low-grade serous tumors with histologic transformation to high grade have both low and high grade morphologic/molecular features, an exception to the dualistic classification in ovarian serous. Michael Herman Chui Team Ovary, Memorial Sloan Kettering Cancer Center pubmed.ncbi.nlm.nih.gov/40327333/

Most uterine carcinosarcomas have detectable TROP2 expression. In an innovative study by Sara Moufarrij and team, organoid models showed encouraging response to TROP2 targeted antibody drug conjugate sacituzumab govitecan. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus pubmed.ncbi.nlm.nih.gov/40344963/

We were so fortunate to have a fantastic discussion with world-renowned expert Dr. Pei Hui MD PhD regarding diagnosis and management of gestational trophoblastic neoplasia as part of our departmental lecture series program. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus

In a new paper Moe Byrne MD MSCR and team assessed feasibility of identifying mutations (TM) in peritoneal washings in #endometrial cancer. Mutational analysis is feasible, and a substantial subset with suspicious washings had TMs detected. MSKCC Team Uterus pubmed.ncbi.nlm.nih.gov/40347837/

Fantastic work for a very important clinical trial in patients with #ovarian cancer by Oliver Zivanovic and team in Heidelberg! Team Ovary, Memorial Sloan Kettering Cancer Center

For those who were unable to attend the 2025 ESGO meeting earlier this year, please take a look at these highlights with experts in key areas of gynecologic oncology, including Nadeem R. Abu-Rustum discussing fertility preservation. MSKCC Team Uterus pubmed.ncbi.nlm.nih.gov/40409204/

Important new study of prognostic implications of estrogen receptor (ER) expression in no specific molecular profile (NSMP) #endometrial cancer. ER+ was associated with better survival outcomes in the NSMP group. Amir Momeni MSKCC Team Uterus pubmed.ncbi.nlm.nih.gov/40414144/

Learning 👩‍🏫from three SCT past presidents and president elect Alexia Iasonos at #MSKBiostats seminar series. Discussing 💬patient centric #ClinicalTrials SCTorg

Team Ovary’s Vance Broach would make a fantastic addition to the IGCS Board of Directors. Voting closes June 10, so don’t miss your opportunity to cast your ballot. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus Read more about Dr. Broach and his vision here: igcs.org/board-of-direc…

🚨Today kicks off #ASCO25. Follow along on our MSK social channels from May 30-June 3 for onsite updates, and read about the latest #cancerresearch from our MSK experts here: bit.ly/43lJ7qA (ASCO)

Read more about research from Alicia Latham, MD,MS aimed to investigate the potential of Pap-derived #ctDNA (Pap-ctDNA) as a novel noninvasive tool for EC detection from ASCO. #ASCO25

Fantastic work currently being presented ASCO on a very important topic in #endometrialcancer by Weill Cornell Medicine resident Dr. Judy Wang. Ying Liu MSKCC Team Uterus

Check out Ariadna Roqué Lloveras and her awesome #ASCO25 poster building on work from Team Ovary, Memorial Sloan Kettering Cancer Center looking at #breastcancer after #ovariancancer in this with germline mutations in non-BRCA HR genes, shockingly none! Memorial Sloan Kettering Cancer Center MSK Department of Medicine

Get ready for the results our The Patient-Centered Outcomes Research Institute funded trial comparing music therapy with cognitive behavioral therapy for anxiety symptoms in cancer survivors.

Promising combo of Pembro + Olaparib in p53 aberrant/CN-H #endometrialcancer presented by Maria Rubinstein, MD at #ASCO25! We need more biomarkers to find those long term responders. MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center MSK Department of Medicine

So proud of Sara Moufarrij who is teaching us all about uterine LMS under the guidance of the one and only #marteehensley! MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center MSK Department of Medicine

And that’s a wrap on possibly my hardest month of fellowship thus far (hours-wise) but also one of my most rewarding! So long Orange Team, hello 4th year of fellowship! #atyourcervix Vance Broach Team Ovary, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center

Exciting data for the ovarian cancer community! The final results of the ARIEL3 Phase 3 trial evaluating #rucaparib as maintenance treatment in platinum-sensitive, recurrent ovarian carcinoma are now published. Read the full study: sciencedirect.com/science/articl… #ovarian #Cancer #ARIEL3

Humbled to get this and be a part of such an amazing group of doctors. Can’t make things better alone!! Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus Memorial Sloan Kettering Cancer Center